← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2015Last known activity
Aug 29, 2024
Timeline
2010s
- Jan 1, 2014
Rose Research Center, LLC— Founded
Drugs by trial phase (10 distinct, 15 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06554873Lead sponsorPhase 3Aug 29, 2024
- NCT06088862Lead sponsorPhase 3Dec 15, 2023
- NCT05994703Lead sponsorPhase 2Oct 20, 2023
- NCT06072547CollaboratorN/ASep 11, 2023
- NCT05855343Lead sponsorN/AFeb 14, 2023
- NCT05205811Lead sponsorPhase 3Dec 14, 2021
- NCT05066724Overall official - principal investigatorPhase 2Sep 13, 2021
- NCT04933916CollaboratorPhase 1/Phase 2Jun 10, 2021
- NCT04868253Lead sponsorPhase 2/Phase 3May 19, 2021
- NCT04388319Lead sponsorPhase 3Jun 1, 2020
- NCT04210180Reponsible party - principal investigatorPhase 2/Phase 3Nov 19, 2019
- NCT04210180Lead sponsorPhase 2/Phase 3Nov 19, 2019
- NCT04188106Reponsible party - principal investigatorPhase 4Jun 10, 2019
- NCT04188106Lead sponsorPhase 4Jun 10, 2019
- NCT02870218Reponsible party - principal investigatorPhase 2May 1, 2019
Details
- Founded
- Raleigh, NC, US Jan 1, 2014
- Last known activity
- Aug 29, 2024